Junichi Kaneko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Junichi Kaneko has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Kiyoshi Hasegawa
Hepato–Biliary–Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
30 shared publications - Norihiro Kokudo
National Center for Global Health and Medicine
21 shared publications - Nobuhisa Akamatsu
Artificial Organ and Transplantation Division and Hepato-Biliary-Pancreatic Surgery, University of Tokyo, Tokyo, Japan
18 shared publications Yasuhiko Sugawara
Hepato-Biliary-Pancreatic Surgery Division, and Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
16 shared publications- Masatoshi Makuuchi
Department of Hepato-Biliary-Pancreatic Surgery, Japanese Red Cross Medical Center, Tokyo, Japan
13 shared publications Nobuhisa Akamatsu
Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
12 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- p. 1-6
Selective endoscopic nasobiliary drainage to determine the resection range for intraductal papillary neoplasm of the bile duct with an initially indeterminate primary site
Background: Intraductal papillary neoplasm of the bile duct (IPNB) often presents with marked ductal dilatation due to excessive mucin secretion, which can make it challenging to distinguish the primary tumor site from secondary dilatation. Case presentation: An 83-year-old woman presented with obstructive jaundice and bilateral biliary dilatation. Initial imaging, including CT, MRI, and PET-CT, failed to localize the tumor. While the first peroral cholangioscopy (POCS) was unsuccessful due to viscous bile, a second POCS identified a papillary lesion distal to the confluence of the B2 and B3 bile ducts. To determine the appropriate resection range, an endoscopic nasobiliary drainage (ENBD) tube was selectively placed in the right hepatic duct. The drainage of normal-colored, non-viscous bile and subsequent resolution of jaundice suggested that the right-sided dilatation was caused by mucin reflux from the left liver, rather than direct tumor involvement. The patient successfully underwent a curative left hepatectomy, including caudate lobectomy. Histopathology confirmed type 1 IPNB with high-grade atypia (carcinoma in situ) and negative surgical margins. Conclusion: POCS combined with selective ENBD may provide a valuable strategy for determining the surgical extent in mucin-producing IPNB when the primary site is difficult to identify using conventional imaging.
- 18 September 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- p. 1-6
Open AccessSelective endoscopic nasobiliary drainage to determine the resection range for intraductal papillary neoplasm of the bile duct with an initially indeterminate primary site
Background: Intraductal papillary neoplasm of the bile duct (IPNB) often presents with marked ductal dilatation due to excessive mucin secretion, which can make it challenging to distinguish the primary tumor site from secondary dilatation. Case presentation: An 83-year-old woman presented with obstructive jaundice and bilateral biliary dilatation. Initial imaging, including CT, MRI, and PET-CT, failed to localize the tumor. While the first peroral cholangioscopy (POCS) was unsuccessful due to viscous bile, a second POCS identified a papillary lesion distal to the confluence of the B2 and B3 bile ducts. To determine the appropriate resection range, an endoscopic nasobiliary drainage (ENBD) tube was selectively placed in the right hepatic duct. The drainage of normal-colored, non-viscous bile and subsequent resolution of jaundice suggested that the right-sided dilatation was caused by mucin reflux from the left liver, rather than direct tumor involvement. The patient successfully underwent a curative left hepatectomy, including caudate lobectomy. Histopathology confirmed type 1 IPNB with high-grade atypia (carcinoma in situ) and negative surgical margins. Conclusion: POCS combined with selective ENBD may provide a valuable strategy for determining the surgical extent in mucin-producing IPNB when the primary site is difficult to identify using conventional imaging.
- Open Access
- 16 May 2025
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 18 (4) , 1-5
Intraduodenal wall recurrence 11 years after distal pancreatectomy for pancreatic ductal adenocarcinoma
Although late recurrence of pancreatic ductal adenocarcinoma (PDAC) is rare, it has been observed in local or regional lymph nodes, as well as in the liver, lung, or peritoneum. We report the first case of intraduodenal wall recurrence 11 years after distal pancreatectomy for PDAC.
- 16 May 2025
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 18 (4) , 1-5
Open AccessIntraduodenal wall recurrence 11 years after distal pancreatectomy for pancreatic ductal adenocarcinoma
Although late recurrence of pancreatic ductal adenocarcinoma (PDAC) is rare, it has been observed in local or regional lymph nodes, as well as in the liver, lung, or peritoneum. We report the first case of intraduodenal wall recurrence 11 years after distal pancreatectomy for PDAC.
- 20 April 2025
- Vol. 50 (1) , 10-13
Sigmoid Colon Perforation After Upper Gastrointestinal Series in Two Japanese Men: A Case Report.
Colorectal perforation following an upper gastrointestinal series is rare. The majority of patients are women. Only 4 cases of perforation have been reported in men with the English literature. Here, we report two more cases of sigmoid colon perforation after an upper gastrointestinal series in men.
- 20 April 2025
- Vol. 50 (1) , 10-13
Sigmoid Colon Perforation After Upper Gastrointestinal Series in Two Japanese Men: A Case Report.
Colorectal perforation following an upper gastrointestinal series is rare. The majority of patients are women. Only 4 cases of perforation have been reported in men with the English literature. Here, we report two more cases of sigmoid colon perforation after an upper gastrointestinal series in men.
- Open Access
- 8 October 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14869
Fatal Hyperacute Liver Failure due to Varicella Zoster Virus Immediately After Living‐Donor Liver Transplantation: A Case Report and Review of the Literature
Background: Although acute hepatitis caused by varicella zoster virus mostly develops in immunocompromised patients, hyperacute liver failure is very rare. To our knowledge, there are no previous reports on liver transplant patients.Methods: We report the first case of fatal hyperacute liver failure due to varicella zoster virus immediately after living‐donor liver transplantation without cutaneous lesions and review the literature.Result: The present case exhibited rapid development and progression of acute liver failure from postoperative days 11–13, despite being seropositive for varicella zoster virus but unvaccinated and on immunosuppression before transplantation. Especially in solid organ transplantation, only six cases of severe acute liver failure that included hepatic encephalopathy and/or impaired consciousness and sudden extremely high (> 4000 U/L) serum aspartate aminotransferase levels have been reported in heart, lung, and kidney transplant patients.Conclusions: Early diagnosis of hyperacute liver failure due to varicella zoster virus is challenging because the disease progresses rapidly and skin lesions are absent.
- 8 October 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14869
Open AccessFatal Hyperacute Liver Failure due to Varicella Zoster Virus Immediately After Living‐Donor Liver Transplantation: A Case Report and Review of the Literature
Background: Although acute hepatitis caused by varicella zoster virus mostly develops in immunocompromised patients, hyperacute liver failure is very rare. To our knowledge, there are no previous reports on liver transplant patients.Methods: We report the first case of fatal hyperacute liver failure due to varicella zoster virus immediately after living‐donor liver transplantation without cutaneous lesions and review the literature.Result: The present case exhibited rapid development and progression of acute liver failure from postoperative days 11–13, despite being seropositive for varicella zoster virus but unvaccinated and on immunosuppression before transplantation. Especially in solid organ transplantation, only six cases of severe acute liver failure that included hepatic encephalopathy and/or impaired consciousness and sudden extremely high (> 4000 U/L) serum aspartate aminotransferase levels have been reported in heart, lung, and kidney transplant patients.Conclusions: Early diagnosis of hyperacute liver failure due to varicella zoster virus is challenging because the disease progresses rapidly and skin lesions are absent.
- 3 May 2024
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 70 (11) , 1008-1014
Three-Dimensional Bio-Printed Tubular Tissue Using Dermal Fibroblast Cells as a New Tissue-Engineered Vascular Graft for Venous Replacement
The current study was a preliminary evaluation of the feasibility and biologic features of three-dimensionally bio-printed tissue-engineered (3D bio-printed) vascular grafts comprising dermal fibroblast spheroids for venous replacement in rats and swine. The scaffold-free tubular tissue was made by the 3D bio-printer with normal human dermal fibroblasts. The tubular tissues were implanted into the infrarenal inferior vena cava of 4 male F344-rnu/rnu athymic nude rats and the short-term patency and histologic features were analyzed. A larger 3D bio-printed swine dermal fibroblast-derived prototype of tubular tissue was implanted into the right jugular vein of a swine and patency was evaluated at 4 weeks. The short-term patency rate was 100%. Immunohistochemistry analysis showed von Willebrand factor positivity on day 2, with more limited positivity observed on the luminal surface on day 5. Although the cross-sectional area of the wall differed significantly between preimplantation and days 2 and 5, suggesting swelling of the tubular tissue wall (both p < 0.01), the luminal diameter of the tubular tissues was not significantly altered during this period. The 3D bio-printed scaffold-free tubular tissues using human dermal or swine fibroblast spheroids may produce better tissue-engineered vascular grafts for venous replacement in rats or swine.
- 3 May 2024
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 70 (11) , 1008-1014
Three-Dimensional Bio-Printed Tubular Tissue Using Dermal Fibroblast Cells as a New Tissue-Engineered Vascular Graft for Venous Replacement
The current study was a preliminary evaluation of the feasibility and biologic features of three-dimensionally bio-printed tissue-engineered (3D bio-printed) vascular grafts comprising dermal fibroblast spheroids for venous replacement in rats and swine. The scaffold-free tubular tissue was made by the 3D bio-printer with normal human dermal fibroblasts. The tubular tissues were implanted into the infrarenal inferior vena cava of 4 male F344-rnu/rnu athymic nude rats and the short-term patency and histologic features were analyzed. A larger 3D bio-printed swine dermal fibroblast-derived prototype of tubular tissue was implanted into the right jugular vein of a swine and patency was evaluated at 4 weeks. The short-term patency rate was 100%. Immunohistochemistry analysis showed von Willebrand factor positivity on day 2, with more limited positivity observed on the luminal surface on day 5. Although the cross-sectional area of the wall differed significantly between preimplantation and days 2 and 5, suggesting swelling of the tubular tissue wall (both p < 0.01), the luminal diameter of the tubular tissues was not significantly altered during this period. The 3D bio-printed scaffold-free tubular tissues using human dermal or swine fibroblast spheroids may produce better tissue-engineered vascular grafts for venous replacement in rats or swine.
- Open Access
- 1 April 2024
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 9, 23
Resection and reconstruction of the largest abdominal vein system (the inferior vena cava, hepatic, and portal vein): a narrative review
Background and Objective: As tumors invade major abdominal veins, surgical procedures are transformed from simple and basic to complicated and challenging. In this narrative review, we focus on what is currently known and not known regarding the technical aspects of major abdominal venous resection and its reconstruction, patency, and oncologic benefit in a cross-cutting perspective. Methods: A systematic literature search was performed in PubMed and Semantic Scholar from inception up to October 18, 2023. We reviewed 106 papers by title, abstract, and full text regarding resection or reconstruction of the inferior vena cava, hepatic vein confluence, portal vein (PV), and middle hepatic vein (MHV) tributaries in living donor liver transplantation (LDLT) in a cross-cutting perspective. Key Content and Findings: The oncologic benefit of aggressive hepatic vein resection with suitable reconstruction against adenocarcinoma remains unclear, and further studies are required to clarify this point. A superior mesenteric/PV resection is now a universal, indispensable, and effective procedure for pancreatic ductal adenocarcinoma. Although many case series using tailor-made autologous venous grafts have been reported, not only size mismatch but also additional surgical incisions and a longer operation time remain obstacles for venous reconstruction. The use of autologous alternative tissue remains only an alternative procedure because the patency rate of customized tubular conduit type to interpose or replace the resected vein is not known. Unlike arterial replacement, venous replacement using synthetic vascular grafts is still rarely reported and there are several inherent limitations except for reconstruction of tributaries of MHV in LDLT. Conclusions: Various approaches to abdominal vein resection and replacement or reconstruction are technically feasible with satisfactory results. Synthetic vascular grafts may be appropriate but have a certain rate of complications.
- 1 April 2024
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 9, 23
Open AccessResection and reconstruction of the largest abdominal vein system (the inferior vena cava, hepatic, and portal vein): a narrative review
Background and Objective: As tumors invade major abdominal veins, surgical procedures are transformed from simple and basic to complicated and challenging. In this narrative review, we focus on what is currently known and not known regarding the technical aspects of major abdominal venous resection and its reconstruction, patency, and oncologic benefit in a cross-cutting perspective. Methods: A systematic literature search was performed in PubMed and Semantic Scholar from inception up to October 18, 2023. We reviewed 106 papers by title, abstract, and full text regarding resection or reconstruction of the inferior vena cava, hepatic vein confluence, portal vein (PV), and middle hepatic vein (MHV) tributaries in living donor liver transplantation (LDLT) in a cross-cutting perspective. Key Content and Findings: The oncologic benefit of aggressive hepatic vein resection with suitable reconstruction against adenocarcinoma remains unclear, and further studies are required to clarify this point. A superior mesenteric/PV resection is now a universal, indispensable, and effective procedure for pancreatic ductal adenocarcinoma. Although many case series using tailor-made autologous venous grafts have been reported, not only size mismatch but also additional surgical incisions and a longer operation time remain obstacles for venous reconstruction. The use of autologous alternative tissue remains only an alternative procedure because the patency rate of customized tubular conduit type to interpose or replace the resected vein is not known. Unlike arterial replacement, venous replacement using synthetic vascular grafts is still rarely reported and there are several inherent limitations except for reconstruction of tributaries of MHV in LDLT. Conclusions: Various approaches to abdominal vein resection and replacement or reconstruction are technically feasible with satisfactory results. Synthetic vascular grafts may be appropriate but have a certain rate of complications.
- 28 February 2024
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 47 (3) , 190-197
Thick silk fibroin vascular graft: A promising tissue-engineered scaffold material for abdominal vein grafts in middle-sized mammals
Abdominal vein replacement with synthetic tissue-engineered vascular grafts constructed from silk-based scaffold material has not been reported in middle-sized mammals. Fourteen canines that underwent caudal vena cava replacement with a silk fibroin (SF) vascular graft (15 mm long and 8 mm diameter) prepared with natural silk biocompatible thread were allocated to two groups, thin and thick SF groups, based on the graft wall thickness. The short-term patency rate and histologic reactions were compared. The patency rate at 2 weeks after replacement in the thin and thick SF groups was 50% and 88%, respectively ( p = 0.04). CD31-positive endothelial cells covered the luminal surface of both groups at 4 weeks. The elastic modulus of the thick SF graft was significantly better than that of the thin SF graft (0.0210 and 0.0007 N/m2, p < 0.01). Roundness of thick SF groups ( o = 0.8 mm) was better than thin SF ( o = 2.0 mm). There was significant difference between the groups ( p = 0.01). SF vascular grafts are a promising tissue-engineered scaffold material for abdominal venous system replacement in middle-sized mammals, with thick-walled grafts being superior to thin-walled grafts.
- 28 February 2024
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 47 (3) , 190-197
Thick silk fibroin vascular graft: A promising tissue-engineered scaffold material for abdominal vein grafts in middle-sized mammals
Abdominal vein replacement with synthetic tissue-engineered vascular grafts constructed from silk-based scaffold material has not been reported in middle-sized mammals. Fourteen canines that underwent caudal vena cava replacement with a silk fibroin (SF) vascular graft (15 mm long and 8 mm diameter) prepared with natural silk biocompatible thread were allocated to two groups, thin and thick SF groups, based on the graft wall thickness. The short-term patency rate and histologic reactions were compared. The patency rate at 2 weeks after replacement in the thin and thick SF groups was 50% and 88%, respectively ( p = 0.04). CD31-positive endothelial cells covered the luminal surface of both groups at 4 weeks. The elastic modulus of the thick SF graft was significantly better than that of the thin SF graft (0.0210 and 0.0007 N/m2, p < 0.01). Roundness of thick SF groups ( o = 0.8 mm) was better than thin SF ( o = 2.0 mm). There was significant difference between the groups ( p = 0.01). SF vascular grafts are a promising tissue-engineered scaffold material for abdominal venous system replacement in middle-sized mammals, with thick-walled grafts being superior to thin-walled grafts.
- Open Access
- 8 December 2023
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 31 (4) , 243-250
A data‐informed timeline for hospital discharge with a reasonably low risk of unplanned readmission after open and minimally invasive liver resections
Background: Postoperative complications following liver resection remain high, ranging from 20% to 50%. Patients are hospitalized for a certain period of time following liver resection because of the risk of postoperative complications. We hypothesized that the risk of complications decreases with each complication‐free postoperative day after open and minimally invasive liver resections and can be stratified using a recently reported three‐level complexity classification.Methods: Patients undergoing first liver resection without concomitant other organ resections between 2006 and 2019 were included. The three‐level complexity classification was used to categorize liver resection procedures into grades I–III. We assessed the rate of cumulative postoperative complications from the time of liver resection to the time of post‐hepatectomy complications (≥ Clavien–Dindo grade II).Results: Of the 911 patients included, 200 underwent resection of grade I procedures, 185 underwent resection of grade II procedures, and 526 underwent resection of grade III procedures. The risks of post‐hepatectomy complications changed over time and were stratified by surgical complexity. For patients at the time of liver resection, the estimated 30‐day complication rate was 21.8% for open grade I resection, 26.7% for open grade II resection, 38.4% for open grade III resection, 8.6% for laparoscopic grade I resection, and 12.5% for laparoscopic grade II resection. For patients without complications at 7 days, the estimated 30‐day complication rate decreased to 2.1% for open grade I, 9.2% for open grade II, 17.6% for open grade III, 1.3% for laparoscopic grade I, and 4.5% for laparascopic grade II.Conclusions: The post‐hepatectomy complication risks were stratified by surgical complexity, liver resection approach, and the period without complication after liver resection.
- 8 December 2023
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 31 (4) , 243-250
Open AccessA data‐informed timeline for hospital discharge with a reasonably low risk of unplanned readmission after open and minimally invasive liver resections
Background: Postoperative complications following liver resection remain high, ranging from 20% to 50%. Patients are hospitalized for a certain period of time following liver resection because of the risk of postoperative complications. We hypothesized that the risk of complications decreases with each complication‐free postoperative day after open and minimally invasive liver resections and can be stratified using a recently reported three‐level complexity classification.Methods: Patients undergoing first liver resection without concomitant other organ resections between 2006 and 2019 were included. The three‐level complexity classification was used to categorize liver resection procedures into grades I–III. We assessed the rate of cumulative postoperative complications from the time of liver resection to the time of post‐hepatectomy complications (≥ Clavien–Dindo grade II).Results: Of the 911 patients included, 200 underwent resection of grade I procedures, 185 underwent resection of grade II procedures, and 526 underwent resection of grade III procedures. The risks of post‐hepatectomy complications changed over time and were stratified by surgical complexity. For patients at the time of liver resection, the estimated 30‐day complication rate was 21.8% for open grade I resection, 26.7% for open grade II resection, 38.4% for open grade III resection, 8.6% for laparoscopic grade I resection, and 12.5% for laparoscopic grade II resection. For patients without complications at 7 days, the estimated 30‐day complication rate decreased to 2.1% for open grade I, 9.2% for open grade II, 17.6% for open grade III, 1.3% for laparoscopic grade I, and 4.5% for laparascopic grade II.Conclusions: The post‐hepatectomy complication risks were stratified by surgical complexity, liver resection approach, and the period without complication after liver resection.